Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients.
Maagdenberg, Hedy
Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients. [electronic resource] - Pharmacogenomics 10 2018 - 1195-1202 p. digital
Publication Type: Journal Article
1744-8042
10.2217/pgs-2018-0095 doi
Adolescent
Age Factors
Anticoagulants--administration & dosage
Child
Child, Preschool
Cytochrome P-450 CYP2C9--genetics
Cytochrome P-450 CYP3A--genetics
Female
Follow-Up Studies
Genotype
Humans
Infant
Male
Pharmacogenetics--methods
Phenprocoumon--administration & dosage
Polymorphism, Single Nucleotide--genetics
Retrospective Studies
Vitamin K Epoxide Reductases--genetics
Effects of age and genetic variations in VKORC1, CYP2C9 and CYP3A4 on the phenprocoumon dose in pediatric patients. [electronic resource] - Pharmacogenomics 10 2018 - 1195-1202 p. digital
Publication Type: Journal Article
1744-8042
10.2217/pgs-2018-0095 doi
Adolescent
Age Factors
Anticoagulants--administration & dosage
Child
Child, Preschool
Cytochrome P-450 CYP2C9--genetics
Cytochrome P-450 CYP3A--genetics
Female
Follow-Up Studies
Genotype
Humans
Infant
Male
Pharmacogenetics--methods
Phenprocoumon--administration & dosage
Polymorphism, Single Nucleotide--genetics
Retrospective Studies
Vitamin K Epoxide Reductases--genetics